Leukemia Survival Improved By Infusion Of Stem Cells And Specially Generated T-Cells From Same Donor

In a significant advance for harnessing the immune system to treat leukemias, researchers at Fred Hutchinson Cancer Research Center for the first time have successfully infused large numbers of donor T-cells specific for a key anti-leukemic antigen to prolong survival in high-risk and relapsed leukemia patients after stem cell transplantation.

http://www.medilexicon.com/medicalnews.php?newsid=256984